National Vaccine Institute and WHO Partner to Strengthen Ghana's Clinical Trial Ecosystem for Vaccine Sovereignty

Ghana is taking a significant step towards medical self-sufficiency as the National Vaccine Institute (NVI) partners with the World Health Organization (WHO) to enhance the country's clinical trials ecosystem. This strategic initiative, funded by the European Union and other international partners, marks the launch of a pilot program utilizing the WHO’s benchmarking tool for institutional capability in clinical trials. By standardizing the assessment of clinical research institutions, the project aims to ensure that Ghana’s medical research infrastructure meets rigorous international standards for ethics, governance, and operational quality.

During the launch event, Deputy Minister of Health Dr. Grace Ayensu-Danquah underscored the importance of the initiative in the context of regional health sovereignty. She emphasized that building specialized centers of excellence through regional collaboration is essential for Africa's health security. The initiative is designed to identify and bridge gaps in the current research landscape, providing a roadmap for institutions to upgrade their capabilities in managing complex clinical trials. This focus on high-quality operations is expected to attract more international research partnerships and investment into Ghana’s growing pharmaceutical and medical research sectors.

Dr. Sodzi Sodzi-Tettey, CEO of the National Vaccine Institute, highlighted that the systematic improvement of institutional capabilities is a prerequisite for achieving Ghana's ambitious goal of vaccine self-reliance. He noted that the ability to conduct rigorous, end-to-end clinical trials is a critical pillar in the journey toward complete local vaccine manufacturing. By strengthening the foundational ecosystem for clinical research today, the NVI and its partners are positioning Ghana as a hub for medical innovation in West Africa, ensuring the nation is better prepared for future public health challenges through localized production and scientific independence.